ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1698

Sex-Related Differences and Trends In Mortality Of Juvenile-Onset Systemic Lupus Erythematosus (SLE) In The United States Over The Last Forty Years, 1971-2010

Eric Y. Yen1, Jennifer M.P. Woo2 and Deborah K. McCurdy3, 1Pediatrics/Rheumatology, UCLA Division of Pediatric Rheumatology, Los Angeles, CA, 2Pediatric Rheumatology, Mattel Children's Hospital, University of California, Los Angeles, Los Angeles, CA, 3Pediatric Rheumatology, UCLA Division of Pediatric Rheumatology, Los Angeles, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: morbidity and mortality, Pediatric rheumatology, pediatrics and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Title: Epidemiology and Health Services Research II: Epidemiology in Systemic Lupus Erythematosus and Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:  To date, SLE-specific mortality studies in children and adolescents are few.  Estimations of mortality in adult cohorts of SLE patients have shown that male patients often demonstrate increased mortality, suggesting worse disease severity and prognosis in males.  However, these studies are limited because they estimate mortality over a finite period rather than over the lifetime of a cohort of subjects.  In this study, we analyzed SLE-specific mortality data for all children and adolescents in the United States over the past 40 years and estimated the sex difference in mortality rates over their lifetime.

Methods:  We studied mortality data from the National Center for Health Statistics (NCHS) from the period of 1971-2010, divided into 4 cohorts based on 10 year periods.  NCHS states that over 99% of all deaths in the United States are registered.  We examined death certificates for all children and adolescents ages 0-19 years old with systemic lupus erythematosus (ICD10: M32.0, ICD9: 710.0, ICD8: 734.1) listed as the underlying cause of death.  Age groups, crude mortality rates per 100,000 persons (=number of deaths/population*100,000), and adjusted crude mortality rates (thus removing the effect of sex difference in SLE prevalence) were calculated.  We utilized previously published data of SLE prevalence in children according to sex as the standard population for our adjusted crude mortality calculation (=crude mortality rate/prevalence of SLE per 100,000 in females and males).

Results:  Of the 3,130,638,696 mortality records examined, 716, 415, 343, and 310 SLE-specific mortalities for ages 0-19 were identified during the periods of 1971-80, 1981-90, 1991-00, 2001-10 respectively.  Crude mortality rate per 100,000 children has decreased over the last forty years from 1971 to 2010 (Fig 1).  The absolute numbers of deaths attributed to SLE decreased from 610 (female, 85%) and 106 (male, 15%) cases during 1971-80 to 253 (female, 82%) and 57 (male, 18%) cases during 2001-10.  For all years, SLE-specific deaths were significantly greater among females than males.  After adjusting for the increased SLE prevalence in females, the sex difference in mortality between females and males diminished (Fig 2).

Conclusion:   Mortality rates from juvenile-onset SLE appear to be declining in children and adolescents over the past 40 years.  Although females still account for 82% of the total deaths due to SLE in children from 2001-2010, the overall mortality rates in males are comparable to females after correcting for increased prevalence of SLE in females.

Crude Mortality Rate per 100,000 children and adolescents from 1971-2010  

  


Disclosure:

E. Y. Yen,
None;

J. M. P. Woo,
None;

D. K. McCurdy,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sex-related-differences-and-trends-in-mortality-of-juvenile-onset-systemic-lupus-erythematosus-sle-in-the-united-states-over-the-last-forty-years-1971-2010/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology